Our website uses cookies. By clicking on accept, you give your consent to the use of cookies as per our Privacy Policy.
30 Nov, 2023
Multiple Myeloma, a complex and challenging blood cancer, has seen significant advancements in treatment, especially in countries like India. This blog aims to explore the current landscape of Multiple Myeloma treatment in India, offering insights into diagnosis, treatment options, and patient care.
Find the right cosmetic procedure for your needs.
We specialize in a wide range of cosmetic procedures
Multiple myeloma is often referred to as a "silent disease" because it can develop slowly and its symptoms can be subtle, leading to delayed diagnosis. Common signs and symptoms of multiple myeloma include:
The diagnosis of multiple myeloma typically involves several steps and a combination of tests:
1. Clinical Evaluation: A healthcare provider will conduct a thorough medical history and physical examination, paying attention to symptoms such as bone pain, fatigue, and signs of kidney dysfunction.
2. Blood Tests: Blood tests are essential in the diagnostic process. Common blood tests include:
3. Urine Tests: A 24-hour urine collection may be performed to detect the presence of Bence Jones proteins, which are abnormal proteins produced by myeloma cells and excreted in the urine.
Once a diagnosis is confirmed, further tests, such as cytogenetic studies and skeletal surveys, may be performed to determine the stage and severity of the disease. Treatment plans are then developed based on the specific characteristics of the myeloma and the patient's overall health.
1. Chemotherapy is a treatment approach that involves the use of potent drugs designed to either kill cancer cells or slow down their growth. In the context of multiple myeloma, chemotherapy is often employed as an initial treatment, particularly for patients with advanced disease.
The primary goal of chemotherapy is to reduce the number of myeloma cells within the body, alleviate associated symptoms, and improve the patient's overall health. Chemotherapy drugs are typically administered through intravenous (IV) injections or taken orally. The specific drugs and treatment regimen are determined based on the patient's individual condition and their response to the therapy. While chemotherapy can be effective in targeting cancer cells, it can also lead to side effects such as nausea, fatigue, and a decrease in blood cell counts, which require close monitoring and management by healthcare professionals.
2. Targeted Therapy is another important treatment approach for multiple myeloma. These therapies involve the use of medications that are designed to target specific molecules or pathways that play a role in the growth and proliferation of cancer cells. Targeted therapies, such as proteasome inhibitors and immunomodulatory drugs, are often used either in combination with other treatments or as maintenance therapy to help control myeloma cells by interfering with certain proteins critical to their survival.
These drugs are typically administered orally, making them more convenient for patients. However, it's important to note that they can also have side effects, which can include neuropathy (nerve damage) and changes in blood cell counts. Close monitoring and management of these side effects are essential during treatment.
3. Stem Cell Transplant is a more intensive treatment option for multiple myeloma. This procedure involves a two-step process. First, high-dose chemotherapy is administered to the patient to eradicate myeloma cells in the bone marrow. Following this, either the patient's own (autologous) or a donor's (allogeneic) stem cells are infused back into the patient's body to replenish the bone marrow and restore blood cell production. Autologous stem cell transplant is often considered for younger and healthier patients, as it carries lower risks compared to allogeneic transplants.
The main objective of this treatment is to achieve a deeper remission by eradicating myeloma cells and allowing the regeneration of healthy bone marrow. The decision to pursue this option depends on various factors, including the patient's age, overall health, and the stage of the disease.
4. Radiation Therapy is a treatment method that employs high-energy beams to target and eliminate cancer cells or reduce the size of tumors. In the context of multiple myeloma, radiation therapy is frequently used to provide relief from pain caused by bone lesions or to treat localized myeloma that may be affecting specific areas.
The primary objective of radiation therapy is to alleviate discomfort, strengthen bones, and shrink tumors in order to enhance the patient's quality of life. Unlike some other treatments, radiation therapy is non-invasive and does not require surgical procedures.
5. CAR T-cell Therapy: CAR T-cell therapy is an emerging and innovative form of immunotherapy that shows great promise in the treatment of multiple myeloma. This therapy involves the modification of a patient's own T-cells (a type of immune cell) to recognize and target myeloma cells more effectively.
T-cells are extracted from the patient, genetically engineered to express chimeric antigen receptors (CARs) that specifically target myeloma cells, and then infused back into the patient. Once inside the body, these modified T-cells can seek out and destroy myeloma cells. CAR T-cell therapy is currently being studied in clinical trials, and it represents a potential breakthrough for patients who have not responded to other treatments.
6. Maintenance Therapy: Maintenance therapy is an ongoing treatment given after the initial therapy with the goal of preventing disease relapse. In multiple myeloma, maintenance therapy is often administered using drugs like lenalidomide. These drugs help to prolong the period of remission, delaying the progression of the disease.
Maintenance therapy is a crucial strategy to manage multiple myeloma as a chronic condition and extend the time during which the disease remains under control.
7. Personalized Medicine: Personalized medicine involves a tailored approach to treatment based on the specific molecular characteristics of a patient's myeloma cells. Molecular profiling and genetic testing are conducted to identify unique mutations or biomarkers in the cancer cells.
This information is then used to select treatments that are more likely to be effective for that particular patient. Personalized medicine is advancing the field of oncology by optimizing treatment choices and potentially improving outcomes for individuals with multiple myeloma.
9. Supportive Therapies: Supportive therapies encompass various complementary approaches designed to manage side effects and improve the overall well-being of individuals undergoing treatment for multiple myeloma. These therapies may include acupuncture, massage, meditation, and other techniques that can help alleviate treatment-related symptoms, reduce stress, and enhance the patient's overall sense of well-being.
While they do not directly treat the cancer, supportive therapies can play a valuable role in the holistic care of patients with multiple myeloma.
It involves a series of carefully planned sessions where patients receive targeted radiation precisely directed at the affected areas. This precision helps minimize damage to healthy surrounding tissues, making it an effective and well-tolerated treatment option.
In conclusion, India has several world-class treatment centers and expert doctors specializing in Multiple Myeloma care. The country's healthcare infrastructure is equipped to provide comprehensive treatment options for patients. Health insurance coverage varies, so it's essential for patients to understand the specifics of their policies.
Our Offices
US
16192 Coastal Highway, Lewes, United States of America.
SG
Vision Exchange, # 13-30, No-02 Venture Drive, Singapore-608526
KSA
3738 King Abdullah Branch Rd, 6258 Al Muhammadiyah Dist, 12362, Riyadh, Saudi Arabia
UK
Level 1, Devonshire House, 1 Mayfair Place, Mayfair W1J 8AJ United Kingdom
IN
2nd Floor, Omaxe Square, Jasola, Behind Apollo Hospital, New Delhi, Delhi 110025
UAE
3401, 34th Floor, Saeed Tower 2, Sheikh Zayed Road, PO Box No. 114429. Dubai, UAE
2024, Healthtrip.com All rights reserved.
Total Hip Replacemen
Upto 80% off
90% Rated
Satisfactory
Total Hip Replacemen
Upto 80% off
90% Rated
Satisfactory
Breast Cancer Surger
Upto 80% off
90% Rated
Satisfactory
Total Knee Replaceme
Upto 80% off
90% Rated
Satisfactory
Total Knee Replaceme
Upto 80% off
90% Rated
Satisfactory
57K+
Patients
Served
38+
Countries
Reached
1037+
Hospitals
Partners